RecruitingNot ApplicableNCT02302482

Predictive Factors and Autonomy Level Change

Predictive Factors of the Autonomy Level Change Related to Memory Disorders


Sponsor

Hospices Civils de Lyon

Enrollment

10,860 participants

Start Date

Nov 1, 2014

Study Type

INTERVENTIONAL

Conditions

Summary

The Alzheimer's disease or related disorders (ADRD) are among the most disabling diseases because of their main features such as cognitive impairment, loss of functional autonomy and behavioural disorders. In absence of current curative treatment, the identification of the predictive risk factors of progression of the disease, evaluated through its main symptoms, represents a major stake of public health. The investigators aimed at developing a database, which includes the patient medical records on a prospective basis, in collaboration with the medical and administrative personal and with the University hospital computer science department. The main objective is to study the predictive factors associated with the change of functional autonomy level, measured every 6 months to 12 months by phone, in a Memory Clinic. The study population would consist in about 1000 patients with ADRD. The length of follow-up of each patient will be 3 years.


Eligibility

Min Age: 65 Years

Inclusion Criteria3

  • Patients who undergo a medical visit in the Memory Clinic for the 1st time
  • Patients living at home or in housing
  • Patients with memory impairment, at all stage of the disease

Exclusion Criteria3

  • Patients in institution
  • Patients under legal protection
  • Patients with a hearing or visual impairment, which dot not allow to carry out the examination

Interventions

OTHERThe Lawton Instrumental Activities of Daily Living score (IADL), and the disability assessment of dementia score (DAD-6

Locations(2)

Hôpital Dugoujon

Caluire-et-Cuire, France

Hospices Civils de Lyon - Hôpital des Charpennes

Lyon, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT02302482


Related Trials